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Abstract: Invadolysin is a novel metalloprotease conserved 
amongst metazoans that is essential for life in Drosophila. 
We previously showed that invadolysin was essential for the 
cell cycle and cell migration, linking to metabolism through 
a role in lipid storage and interaction with mitochondrial 
proteins. In this study we demonstrate that invadolysin 
mutants exhibit increased autophagy and decreased glyco-
gen storage – suggestive of a role for inva dolysin in insulin 
signaling in Drosophila. Consistent with this, effectors of 
insulin signaling were decreased in invadolysin mutants. In 
addition, we discovered that invadolysin was deposited on 
newly synthesized lipid droplets in a PKC-dependent man-
ner. We examined two in vitro models of adipogenesis for 
the expression and localization of inva dolysin. The level 
of invadolysin increased during both murine 3T3-L1 and 
human Simpson-Golabi-Behmel syndrome (SGBS), adipo-
genesis. Invadolysin displayed a dynamic localization to 
lipid droplets over the course of adipogenesis, which may 
be due to the differential expression of distinct invadolysin 
variants. Pharmacological inhibition of adipogenesis abro-
gated the increase in invadolysin. In summary, our results 
on in vivo and in vitro systems highlight an important role 
for invadolysin in insulin signaling and adipogenesis.
Keywords: adipogenesis; insulin signaling; lipid droplets; 
metalloprotease.
Introduction
Proteases – whether aspartic, cysteine, glutamic, aspara-
gine, serine/threonine or metallo – play diverse and crucial 
intracellular and extracellular roles (Rawlings and Barrett, 
1999; Gomis-Ruth, 2003). Invadolysin is a member of the 
M8 family of metzincin metalloproteases strikingly repre-
sented in most metazoans by a single gene, in contrast to 
the multi-gene MMP or ADAM families. Drosophila invadoly­
sin mutant larvae die during the late larval stages with aber-
rantly condensed chromosomes and monopolar spindles in 
dividing larval neuroblasts (McHugh et al., 2004). The inva­
dolysin mutant animals have increased levels of lamin and 
otefin nuclear envelope proteins, and mono- ubiquitinated 
histone H2B (McHugh et al., 2004; Rao et al., 2015). A role 
for invadolysin in cell migration is evident in both Dros­
ophila mutant larvae and zebrafish embryos depleted of 
invadolysin by morpholino interference (McHugh et  al., 
2004; Vass and Heck, 2013). Invadolysin localizes to lipid 
droplets in cultured cell lines (Cobbe et al., 2009) and plays 
a role in metabolism through interaction with ATP synthase 
subunits (Di Cara et  al., 2013). That invadolysin mutant 
larvae have a decreased lipid:protein ratio suggests that the 
enzyme may play a functional role in lipid accumulation 
(Cobbe et al., 2009). Storage of proteins, including core his-
tones, in lipid droplets presents an intriguing link between 
the localization of invadolysin to lipid droplets and the 
abnormal chromosome morphology in invadolysin mutants 
(Cermelli et al., 2006; Li et al., 2012; Welte, 2015).
Lipid droplets were initially considered to be rela-
tively inert organelles whose sole function was to store 
neutral lipids as triglycerides and cholesterol esters (Gold-
berg et al., 2009; Walther and Farese, 2012; Welte, 2015). 
Several studies on lipid droplets have shown these struc-
tures to be dynamic and involved in many vital activities 
(Welte, 2015), including the regulation of lipid homeo-
stasis (Smirnova et al., 2006; Naslavsky et al., 2007) but 
also in less intuitively obvious processes such as protein 
storage (Cermelli et  al., 2006). Morphological changes 
in lipid droplets observed in conditions such as cancer 
(Accioly et al., 2008), Parkinson’s disease (Scherzer et al., 
2003), and longevity regulation (Goldberg et  al., 2009) 
link lipid droplets to vertebrate physiology and disease.
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Lipid droplet proteins are dynamically regulated 
during adipogenesis. The size and number of lipid drop-
lets increases and the levels of lipid droplet associated 
proteins including adipose triglyceride lipase (ATGL), 
CGI-58, perilipin and adipose differentiation-related 
protein or perilipin 2 (ADRP) all increase during adipo-
genesis (Yamaguchi et  al., 2004; Zimmermann et  al., 
2004). We tested the hypothesis that invadolysin levels 
might also change during adipogenesis by examining 
murine 3T3-L1 and human SGBS (Green and Kehinde, 
1976; Wabitsch et  al., 2001; Cobbe et  al., 2009) in vitro 
adipogenesis models. The process of adipogenesis is ini-
tiated by sequential activation of numerous transcription 
factors which act downstream of signaling pathways in 
response to intracellular or extracellular stimuli (Rosen 
and MacDougald, 2006). Insulin signaling plays a critical 
role in promoting lipid accumulation and energy storage 
(Imamura et  al., 2002). Not surprisingly, insulin signal-
ing is also important for adipogenesis. The loss of the 
IRS (insulin receptor substrate), inhibition of PI3K, Akt 
and mTOR (a direct target of Akt) have all been shown to 
inhibit adipogenesis (Sakaue et al., 1998; Kim and Chen, 
2004; Lawrence et al., 2004; Tseng et al., 2004; Rosen and 
MacDougald, 2006).
The mechanism of invadolysin’s localization to 
lipid droplets and its precise function there still remains 
unknown. In the present study, we have utilized invad­
olysin mutants to demonstrate a role for invadolysin in 
insulin signaling in Drosophila. We additionally used a 
starvation/refeeding model to demonstrate that Protein 
Kinase C activity is important for the localization of 
invadolysin to nascent lipid droplets. And finally, by 
utilizing two in vitro adipocyte differentiation systems, 
we demonstrated that the invadolysin increases during 
adipogenesis.
Results
We previously demonstrated that invadolysin localized 
to lipid droplets (LDs) by immunofluorescence of cul-
tured cell lines and biochemically by immunoblotting 
fractionated A375 cells (a human melanoma cell line) 
(Cobbe et  al., 2009). Reduction in fat body thickness 
and cell  cross-sectional area, coupled with a decreased 
 triglyceride : protein ratio in invadolysin mutant larvae 
indicated that invadolysin was functionally involved in 
lipid accumulation. We therefore set out to determine 
whether other parameters of metabolism were disrupted 
in D. invadolysin mutants.
Analysis of autophagy, glycogen 
 accumulation and triglyceride storage
Insulin signaling positively regulates fatty acid and gly-
cogen synthesis, and negatively regulates autophagy via 
the TOR (target of rapamycin) kinase (Halse et al., 2001; 
Jung et al., 2010; Wong and Sul, 2010). LysoTracker stain-
ing is a standard assay to detect autophagy (Munafó and 
Colombo, 2001; Chikte et al., 2014). In Drosophila, the fat 
body is the main lipid storage tissue and major energy 
reserve, similar to mammalian adipocytes. Staining of 
the fat body from control and invadolysin mutant larvae 
with LysoTracker demonstrated that autophagy was 
increased in invadolysin mutants (Figure 1A). We also 
show that the glycogen : protein ratio was significantly 
reduced in invadolysin mutants compared to wild type 
larvae, consistent with a role for invadolysin in insulin 
signaling (Figure 1B).
Feeding wild type Drosophila larvae a high 
sucrose diet significantly increases the triglyceride 
content (Musselman et  al., 2011). To test if the ability 
to accumulate triglyceride was impaired in invadolysin 
mutants, animals were fed a high sucrose diet. On a 
high sucrose diet, wild type larvae had a significantly 
higher  triglyceride : protein ratio than on a control diet 
(Figure  1C). Invadolysin mutant larvae on the other 
hand had a decreased triglyceride : protein ratio on a 
high sucrose diet compared to a control diet (Figure 1C). 
Decrease of the triglyceride : protein ratio in invadoly­
sin mutant larvae fed a high sucrose diet suggested 
that the ability to synthesize or accumulate triglyceride 
was impaired in invadolysin mutants. Our data support 
the reported contention of antagonistic controls on 
autophagy and glycogen accumulation (Wang et  al., 
2001; Zirin et al., 2013).
In vertebrates, triglyceride storage is regulated by 
conserved lipases and LD associated proteins, such as 
perilipin. Perilipin, whose expression and activity are 
regulated by insulin, can promote LD formation (Prusty 
et al., 2002; Holm, 2003; Akimoto et al., 2005; Vereshcha-
gina and Wilson, 2006). Lsd2, the Drosophila homologue 
of perilipin, localizes to LDs when ectopically expressed 
as a GFP-fusion (Miura et  al., 2002). We hypothesized 
that the expression of Lsd2 might be altered in invadoly­
sin mutants. Indeed, protein extracts from 96  h larvae 
showed that the Lsd2 level was decreased in invadolysin 
extracts relative to wild type, with a 2.5-fold decrease in 
96 h invadolysin mutants (Figure 2A, B). The level of Lsd2 
RNA was also decreased to 80% of the wild type level, sug-
gesting control predominantly at the level of translation 
(data not shown).
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Figure 1: Metabolic consequences in invadolysin mutants.
(A) Staining of fat body with LysoTracker from wild type and invadolysin mutant (INV4Y7) third instar larvae demonstrated that autophagy 
was increased in mutants compared to wild type. The images were captured at the same magnification. (B) The glycogen : protein ratio was 
significantly reduced in INV4Y7 mutant larvae compared to wild type larvae (data was analyzed by one-way ANOVA, **p < 0.01). (C) On a high 
sucrose diet, control larvae accumulate significantly higher amounts of triglyceride whereas INV4Y7 mutants are unable to accumulate triglyc-
eride on a high sucrose diet (data was analyzed by one-way ANOVA, *p < 0.05).
Insulin signaling is impaired in invadolysin 
mutants in vivo
Multiple signaling pathways either positively or nega-
tively regulate adipogenesis (Farmer, 2006). Of these, 
insulin signaling (initiated upon binding of insulin to its 
receptor) plays a critical role in promoting lipid accumula-
tion and energy storage. To examine whether the observed 
increase in autophagy and decrease in glycogen and tri-
glyceride accumulation in invadolysin mutants were con-
sequences of impaired insulin signaling, we examined 
markers of insulin signaling in third instar wild type and 
invadolysin mutant larval extracts. While the basal level of 
Akt (a downstream effector of InR) was unchanged in inv­
adolysin mutants, pAkt levels were reduced in invadolysin 
mutants (Figure 2C, D). These data suggest that activation 
of Akt, a downstream mediator of insulin signaling, may 
be disrupted in invadolysin mutant larvae.
As pAkt was decreased in invadolysin mutant larvae, 
we further examined the TOR pathway for additional 
downstream consequences. Activated Akt normally 
phosphorylates TSC2, leading to activation of TOR kinase 
(Inoki et  al., 2002; Manning et  al., 2002; Potter et  al., 
2002). Active TOR phosphorylates S6K (p70 S6 kinase) and 
4E-BP (a translational inhibitor), two critical downstream 
effectors (Fingar and Blenis, 2004). Knockdown of TOR in 
Drosophila has previously been shown to eliminate the 
phosphorylation of S6K and 4E-BP (Yang et al., 2006). We 
thus examined the levels of phosphorylated/activated S6K 
and 4E-BP in wild type and invadolysin mutant larvae. We 
observed significantly reduced levels of pS6K (Figure 2E, 
F) and p4E-BP (Supplementary Figure 1) in invadolysin 
mutant extracts relative to wild type. Due to the decrease 
in the downstream pS6K and p4E-BP effectors, we hypoth-
esize that invadolysin normally plays a positive regulatory 
role in promoting insulin signaling.
The activation of Akt upon insulin signaling also leads 
to the phosphorylation of the FOXO transcription factor, 
leading to the inhibition of 4E-BP expression (Teleman 
et al., 2005). As pAkt was decreased in invadolysin mutant 
larvae, we hypothesized that the expression of d4E-BP in 
invadolysin mutants might be increased. Consistent with 
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Figure 2: Loss of invadolysin resulted in impaired insulin signaling 
in vivo.
Extracts prepared from third instar wild type or INV4Y7 mutant larvae 
were immunoblotted for Lsd2, Akt, pAkt, and p70 S6K (downstream 
components of insulin signaling). Quantification of protein levels 
are shown in panels (B, D, F). (A, B) Immunoblotting demonstrates 
Lsd2 was decreased in invadolysin mutant whole larval extracts. 
(C, D) Immunoblot for Akt and activated pAkt in wild type (Canton S) 
and INV4Y7 larvae. The phospho-form of Akt was decreased, though 
not the unphosphoryated form. (E, F) Immunoblot for p70 S6K in 
wild type and INV4Y7 larvae. These data reveal decreased Lsd2, pAkt 
and p70 S6K in INV4Y7 mutant extracts.
this hypothesis, the level of 4E-BP mRNA was elevated 
in invadolysin mutant larvae (Supplementary Figure 1). 
Collectively, our data demonstrate that upon mutation of 
invadolysin, the phosphorylation of Akt, S6K and 4E-BP 
are all decreased, while 4E-BP appears to be increased (at 
least at the transcript level).
In summary, phosphorylated Akt, S6K and 4E-BP 
(the downstream mediators of insulin signaling) were 
all decreased in invadolysin. Downstream targets of the 
insulin/TOR pathway were also affected: autophagy (as a 
negative target) was increased, while glycogen and triglyc-
eride accumulation (positive targets) were decreased in 
invadolysin mutants. Our results indicate that the insulin 
signaling pathway is impaired in invadolysin mutants.
Serum starvation/refeeding to examine the 
dynamics of invadolysin localization to LDs
We wanted to determine whether the presence of invadoly-
sin on LDs was dynamic and responsive to insulin stimu-
lation. Serum starvation/refeeding (a model for insulin 
stimulation) of cultured vertebrate cell lines leads to dis-
ruption of LDs followed by de novo LD formation (Ozeki 
et al., 2005; Andersson et al., 2006). A375 melanoma cells 
were starved overnight and then re-fed with serum-con-
taining medium to stimulate LD reformation (Figures 3 and 
4A). Under normal cell culture conditions, BODIPY stain-
ing of LDs and counterstaining with invadolysin antibody 
revealed invadolysin ‘rings’ on the surface of LDs (Figures 3 
and 4A). Upon serum starvation, neither LDs nor invad-
olysin ‘rings’ could be detected. Within 30  min of serum 
re-feeding, LDs encircled by invadolysin were observed. 
These structures reached pre-starvation levels by 3  h of 
serum re-feeding. Cells containing 5 or more BODIPY foci 
were identified as LD-positive cells, while those containing 
5 or more invadolysin foci were identified as invadolysin-
positive cells (Figure 4B). LD- and invadolysin-positive cells 
increased with the length of time in fresh serum-containing 
medium. 50% of cells were LD/invadolysin-positive after 
1 h incubation, rising to 100% after 3 h re-feeding. These 
results suggest that invadolysin localized to LDs coincident 
with LD formation. The coincident appearance of invadoly-
sin on LDs could result either from invadolysin recruitment 
to LDs or de novo synthesis of invadolysin. As shown in 
the immunoblots of Figure 4C, the level of invadolysin did 
not dramatically change after starvation. Invadolysin was 
also recruited to newly formed LDs following pretreatment 
of cells with 10 μm cycloheximide for 1 h before refeeding 
(data not shown), suggesting that the localization of invad-
olysin to LDs was not dependent on de novo protein synthe-
sis. We hypothesize that starvation resulted in the dispersal 
of invadolysin into the cytoplasm, which was then recruited 
to newly-formed LDs upon serum feeding.
Protein kinase C requirement for the 
 localization of invadolysin to newly 
 synthesized LDs
Several proteins related to cell signaling such as protein 
kinase C (PKC) δ, diacylglycerol kinase (DGK) δ, PKA, Ras, 
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Figure 3: Invadolysin was recruited to newly formed LDs.
Human A375 melanoma cells were starved in serum-free medium overnight, and then fed fresh medium containing 10% FBS. Cells were fixed 
and stained for LDs (green), invadolysin C-Ab1 (red) and DNA (blue). Neither LDs nor invadolysin foci were detectable following serum starva-
tion. However, both LDs and invadolysin rings were clearly observed after cells were incubated in fresh medium containing 10% FBS. Higher 
magnifications of the areas enclosed by the white boxes are shown in Figure 4A. Scale bar = 20 μm.
Raf and P-MAPK have been shown by proteomic analysis 
to localize to LDs (Turro et al., 2006). PKC α and PKC δ can 
additionally translocate to LDs after stimulation of RAW 
264.7 macrophages with oleic acid (Chen et al., 2002).
To address whether PKC plays a role in the localiza-
tion of invadolysin during the de novo generation of LDs, 
the general PKC inhibitor, Ro31-8220, was added during 
the starvation/refeeding experiment. A375 cells were 
starved for 24 h to disrupt LDs, and then treated with 5 μm 
Ro31-8220 for 1 h. Cells were refed for another 3 h in fresh 
medium containing Ro31-8220, and subsequently ana-
lyzed for invadolysin and LDs. DMSO alone had no effect 
on invadolysin dispersal and relocalization (Figure  5A). 
However, PKC inhibition disrupted the localization of 
invadolysin, with the majority of invadolysin appear-
ing as cytosolic aggregates distinct from LDs (Figure 5B). 
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Figure 4: LDs containing invadolysin increased after refeeding of starved cells.
(A) Three-fold higher magnification of the areas enclosed by white boxes in Figure 3. LDs and invadolysin could not be detected following 
serum starvation, but were clearly observed after cells were incubated in fresh serum-containing medium. Scale bar = 10 μm. (B) Quantita-
tion of LDs following refeeding of starved A375 cells. Cells containing five or more BODIPY foci were identified as BODIPY-positive. The graph 
shows the mean value and standard deviation (SD) from 3 independent experiments where 400–500 cells were counted for each time point. 
LD-positive cells reached pre-starvation levels in 3 h. (C) Protein extracts were prepared from cells cultured in: medium containing 10% FBS, 
serum-free medium (overnight), and fresh serum-containing medium (for 3 h). Invadolysin was detected by immunoblotting using invadoly-
sin 3646 and C-Ab1 antibodies (Cobbe et al. 2009, and Figure 9).
Although LDs still formed when PKC was inhibited, ‘rings’ 
of invadolysin were rarely observed. These data suggest 
that the localization of invadolysin to nascent LDs was 
dependent on PKC activity.
To determine whether invadolysin could relocalize 
to LDs after Ro31-8220 removal, A375 cells were starved 
and refed with fresh medium containing Ro31-8220 
for 3  h. Cells were then incubated with fresh medium 
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Figure 5: Inhibition of protein kinase C blocked recruitment of 
invadolysin to newly formed LDs.
A375 cells were starved in serum-free medium for 24 h. (A) 5 μm 
DMSO or (B) or Ro31-8220 was added to inhibit PKC activity. After 
1 h, cells were refed with fresh medium containing 10% FBS and 
Ro31-8220 and incubated for another 3 h. (A) DMSO does not affect 
the localization of invadolysin to LDs. (B) Upon Ro31-8220 treat-
ment, invadolysin formed aggregates that were distinct from LDs. 
(C) Relocalization of invadolysin to LDs after removal of PKC inhibi-
tor Ro31-8220. A375 cells were treated as in A, but medium lacking 
Ro31-8220 was added after 3 h. Cells were stained for LDs (green) and 
invadolysin (red).
lacking Ro31-8220. While aggregates of invadolysin were 
still observed in cells 1 h after removal of Ro31-8220, after 
16 h invadolysin was apparent on LDs (Figure 5C). This 
experiment suggested that PKC activity was important 
for invadolysin’s localization to LDs.
Protein phosphorylation is a common post-transla-
tional modification used to regulate activity, localization, 
stability or molecular interactions (Bartz et al., 2007). As 
the localization of invadolysin to LDs appeared to be PKC-
dependent, we analysed the sequence of invadolysin for 
evolutionarily conserved PKC phosphorylation sites by 
NetPhosK 1.0 (Blom et al., 2004), NetPhos 2.0 (Blom et al., 
1999), and GPS2.1 (Xue et  al., 2008). Four threonines 
(at positions 220, 269, 458 and 467) in the invadolysin 
sequence scored highly for potential PKC phosphoryla-
tion (Figure 6A).
To determine whether invadolysin may be phospho-
rylated by PKC in vitro, bacterially-expressed recombi-
nant invadolysin fragments were affinity purified and an 
in vitro kinase assay performed. The nearly full-length 
‘GST-VINK’ construct, as well as an N-terminal V1N con-
struct were phosphorylated by protein kinase C in vitro, 
while the C-terminal V1C construct was not (Figure 6B, C). 
These results suggested phosphorylation site(s) within 
the first 300 amino acids of invadolysin. We postulate 
that T220 and/or T269 may be phosphorylated by PKC. 
Both of the corresponding residues in the leishmanoly-
sin sequence map to the surface of the leishmanolysin 
structure (rather than to the interior of the protein). While 
T269 (V261 in leishmanolysin) lies in a pocket, T220 (S219 
in leishmanolysin) is more exposed. We therefore predict 
that T220 in invadolysin is more likely to be phosphoryl-
ated by PKC.
The localization of invadolysin during murine 
3T3-L1 adipogenesis in vitro
The in vivo data from D. invadolysin mutants, coupled 
with the serum starvation/refeeding model suggested 
that invadolysin may play a role in adipogenesis. Adi-
pocyte differentiation is a multi-step process that 
requires growth inhibition by cell-to-cell contact and 
hormonal induction for mitotic clonal expansion, fol-
lowed by accumulation of triacylglycerol storage in LDs 
(Rosen and Spiegelman, 2000). We decided to investi-
gate invadolysin in two vertebrate in vitro adipogenesis 
systems.
To examine the level and localization of LD proteins 
during murine adipogenesis, 3T3-L1 cells were induced to 
differentiate into adipocytes and the subcellular localiza-
tion of invadolysin and perilipin determined by immuno-
fluorescence (Figure 7A). On day 2, invadolysin exhibited 
a punctate staining pattern in the cytosol. At day 4, the 
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Figure 6: Invadolysin can be phosphorylated in vitro by protein kinase C.
(A) Schematic representation of human invadolysin, including predicted signal sequence (orange), metalloprotease (green), and GPI-addition 
(pink) sites. Putative PKC phosphorylation sites (blue arrows) and the truncated invadolysin constructs tagged with GST (gray) or [His]6 at the 
N-terminus are depicted. (B) Coomassie Brilliant Blue stained polyacrylamide gel shows the amount of protein used for the in vitro kinase 
assay. (C) Recombinant invadolysin proteins, GST (negative control) and Histone H1 (positive control) were incubated with PKC and γ-32P-ATP 
and then analyzed by 4–12% NuPAGE and autoradiography. GST-VINK and GST-V1N were phosphorylated by PKC in vitro, while V1C-His was 
not. These results demonstrate that one or more sites within the N-terminal half of invadolysin could be phosphorylated by PKC in vitro.
size of LDs increased and the cells acquired a circular 
morphology. Invadolysin displayed a cytoplasmic ring-
like distribution at days 2 and 4. At day 6, invadolysin 
rings were not as apparent as at earlier times, and inv-
adolysin appeared dispersed in the cytosol of fully dif-
ferentiated adipocytes (day 8). These data suggest that 
invadolysin localized to LDs in the early stages of differ-
entiation, but then disassociated from LDs at later stages. 
Perilipin showed a localization pattern distinct from inv-
adolysin. Perilipin was strikingly localized in the nucleus 
on days 0–2 of differentiation (not previously described). 
However, from day 4 onward, a pronounced ring-like dis-
tribution surrounding LDs was observed (Figure 7A). With 
further culture until day 14 post-differentiation, small and 
large LDs were observed within the same 3T3-L1 adipo-
cyte. Intriguingly, invadolysin appeared to preferentially 
encircle small rather than large LDs, whereas perilipin 
encircled every LD (Figure 7B). These results highlight the 
dynamic nature of LD proteins. Differential localization 
between invadolysin and perilipin may reflect different 
roles played by these proteins.
Invadolysin increases during 3T3-L1 
adipogenesis
In order to determine whether invadolysin mRNA changes 
during 3T3-L1 differentiation, qRT-PCR was performed on 
RNA extracted from 3T3-L1 cells at different times (and 
normalized to actin). The relative expression at various 
time points was further normalized to day 0, in order to 
present the relative change of expression over time. TIP47 
is the only PAT (Perilipin, ADRP and TIP47) protein that 
appears to be functionally unrelated to adipocyte differ-
entiation (Yamaguchi et al., 2004), and its mRNA did not 
change significantly during adipogenesis (Figure 7C). On 
the other hand, invadolysin, ADRP and perilipin mRNA 
all increased to varying degrees during adipocyte differ-
entiation (Figure 7C). Invadolysin mRNA increased gradu-
ally during differentiation reaching a 10-fold increase 
on day 8. ADRP mRNA increased close to 15-fold, while 
the expression of perilipin exhibited a dramatic 100-fold 
increase at day 2 and continued to increase to more than 
250-fold at day 4.
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Figure 7: Determination of invadolysin localization and level during 3T3-L1 adipogenesis.
(A) At different time points in the differentiation protocol, 3T3-L1 cells were fixed and stained for invadolysin (upper) or perilipin (lower). In 
the early stages of differentiation (days 2 and 4), invadolysin was observed surrounding LDs. At day 8, invadolysin appeared dispersed in 
the cytosol of differentiated 3T3-L1 cells. Another LD binding protein, perilipin, was found surprisingly to localize in the nucleus at days 0–2. 
From day 4, perilipin encircled LDs. (B) Day 14 adipocytes were fixed and stained for LDs (green), DNA (blue), and invadolysin or perilipin 
(red). Invadolysin encircled smaller LDs, while perilipin surrounded all LDs. (C) Invadolysin mRNA increased significantly during adipocyte 
differentiation. Total RNA from 3T3-L1 cells undergoing differentiation was analysed by qRT-PCR using appropriate primers and probes 
for the expression of TIP47, invadolysin, ADRP, and perilipin. The expression of each gene was normalized to actin and the fold-change of 
expression was normalized to day 0. Each experiment was performed in triplicate. The graph shows the mean value and standard deviation 
(SD) for 3 independent experiments. For comparison the difference between each day was further analyzed by one-way ANOVA (nonparamet-
ric) in 95% confidence intervals (***p < 0.0001). (D) The expression of invadolysin and perilipin (but not TIP47) increased during adipo-
genesis. Cell lysates from different days during differentiation were prepared. Protein expression was detected by immunoblotting using 
designated antibodies.
As invadolysin mRNA increased during adipocyte dif-
ferentiation, it was important to address whether the level 
of the protein also increased. We compared invadolysin 
protein with other PAT proteins during differentiation. 
While the amount of TIP47 did not change during dif-
ferentiation, we observed a dramatic increase in both 
invadolysin and perilipin upon adipocyte differentiation 
(Figure 7D). These results thus demonstrate a correlation 
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Figure 8: Invadolysin and perilipin mRNA and protein decreased when PKC or PI3K were inhibited.
3T3-L1 cells were induced to differentiate into adipocytes. On day 2, either 5 μm Ro31-8220 (a PKC inhibitor) or 50 μm LY294002 (a PI3K 
inhibitor) was added to cells and the culture medium was replaced with fresh inhibitor-containing medium every 2 days until day 8. 
A–C) Inhibition of adipocyte differentiation was observed after inhibition of PKC, while the effects of PI3K inhibition are shown in panels 
(D)–(F). (A and D) Scale bar = 60 μm. (B and E) mRNA expression of TIP47, invadolysin, and perilipin was quantified by qRT-PCR. The expres-
sion of each gene was normalized to actin and the fold change of expression was normalized to day 2. Data are representative of three 
individual experiments and each experiment was performed in triplicate. The graphs show the mean value and standard deviation (SD) for 
three independent experiments. For differential comparisons, the data were further analyzed by one-way ANOVA (nonparametric) at 95% 
confidence intervals (***p < 0.0001). (C and F) Cell lysates were collected on the days indicated. ‘+I’ indicates treatment with the PKC or PI3K 
inhibitor. TIP47, invadolysin, perilipin and actin were detected by immunoblotting.
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between invadolysin level and progression of 3T3-L1 
adipogenesis.
Inhibition of PKC and PI3K blocked 
3T3-L1 adipogenesis and the elevation 
of  invadolysin and perilipin
A number of studies have suggested that PKC may regu-
late adipocyte differentiation (Fleming et al., 1998; Zhou 
et  al., 2006). While our results showed that the invad-
olysin level did not dramatically change between days 
0–2 of adipogenesis, a significant increase was observed 
between days 2 and 4. Therefore, after induction of dif-
ferentiation by IBMX/DEX/insulin on day 0, the broad- 
spectrum PKC inhibitor Ro31-8220 was added to cells 
on day 2 and incubated until day 8. mRNA and protein 
extracts were prepared before inhibitor treatment on 
day 2, and on day 8 (with and without inhibitor treat-
ment), and analyzed for TIP47, INV, perilipin, and actin. 
In control 3T3-L1 cultures, most cells differentiated into 
mature adipocytes by day 8. However, when PKC was 
inhibited, cells failed to differentiate (Figure 8A). Con-
sistently, the mRNA and protein levels of invadolysin 
and perilipin were decreased in Ro31-8220-treated cells, 
whereas TIP47 expression level did not change when adi-
pocyte differentiation was blocked (Figure 8B, C).
We examined the effects on adipogenesis after treat-
ing cells with a PI3K inhibitor (LY294002) as PI3K is an 
important mediator of insulin’s effects (Rosen and Mac-
Dougald, 2006; Tseng et al., 2004). LY294002 was added 
at day 2 till day 8 to block adipocyte differentiation (Figure 
8D), and mRNA and protein extracts were prepared from 
cells on these days. When PI3K was inhibited, adipocyte 
differentiation was blocked (Figure 8D), and the mRNA 
and protein levels of invadolysin and perilipin were 
decreased (Figure 8E, F). The expression of TIP47 mRNA 
was unaffected by inhibition of PI3K. These data demon-
strate that when adipogenesis was blocked by treatment 
with PKC or PI3K inhibitors, invadolysin and perilipin do 
not increase.
Invadolysin also increased during human 
SGBS adipogenesis in vitro
SGBS cells are a human preadipocyte cell line derived 
from subcutaneous white adipose tissue of a patient suf-
fering from Simpson-Golabi-Behmel syndrome (SGBS), 
an X-linked disorder caused by mutation in the glypican­3 
gene (Xuan et al., 1999; Wabitsch et al., 2001). As invad-
olysin increased during murine 3T3-L1 adipogenesis, we 
set out to determine if invadolysin also increased during 
human SGBS differentiation.
We have detected four alternatively-spliced vari-
ants of invadolysin in human cells (Cobbe et al., 2009), 
depicted in Figure 9A. The N-terminal variants of INV, 
INV.v1 and INV.v2 use an alternate reading frame. Each 
of the two N-terminal variants also has an alternatively 
spliced version (+ 37 and Δ 37), with or without the 37 
amino acids encoded by exon 12. There was no detectable 
change by RT-PCR in the transcript levels of these vari-
ants during SGBS differentiation (Figure 9B–E). INV.v1+37 
was the most prevalent variant at all time points ana-
lysed. Interestingly, this variant most closely resembles 
the single variant expressed in Drosophila. The RT-PCR 
results differ from the qPCR results obtained for 3T3-L1 
cells (Figure 7C), likely reflecting sensitivity differences 
in the techniques.
The morphological changes during SGBS adipogene-
sis are shown in Figure 10A. Over time, cells fill with LDs, 
and the nuclei become compressed in appearance. As 
with 3T3-L1 cells, invadolysin protein increased during 
SGBS adipogenesis (Figure 10B). Utilizing antibodies gen-
erated against different invadolysin peptides (to examine 
distinct variants) demonstrated that translation of inv-
adolysin variants may be regulated during adipogenesis. 
Antibody 3645/6 was raised against a sequence common 
to all predicted human invadolysin variants (Figure 9A), 
upstream of the metalloprotease motif. While the level 
of a 52 kDa form of invadolysin (that we postulate to be a 
processed form) remained constant during adipogenesis, 
the level of a larger 66 kDa form of invadolysin increased 
during SGBS adipogenesis (Figure 10B). The 66 kDa form 
was similar to the predicted full-length size of invadoly-
sin (Table 1).
Examining the distinct INV.v1 and INV.v2 N-terminal 
variants demonstrated additional regulation. Antibod-
ies 4624 and 4888 were designed against distinct peptide 
sequences of the INV.v1 and INV.v2 variants, respectively 
(Figure 9A). The 4624 antibody bound to a 39 kDa band 
that may represent a cleaved region from the N-terminus 
of INV.v1 (Figure 10C). Blotting with 4888 (INV.v2) showed 
the level of a 52  kDa form to remain constant, while a 
66  kDa form of INV.v2 increased during adipogenesis 
(Figure 10D). The patterns observed with the 3646 and 
4888 antibodies were strikingly similar, suggesting that 
the 52 and 66 kDa forms of invadolysin may both derive 
from INV.v2 translation. Table 2 summarizes the change in 
protein levels of different forms of invadolysin. Increase of 
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Figure 9: Analysis of invadolysin alternatively-spliced variants during SGBS adipogenesis.
(A) Schematic of the four alternative splice variants of human invadolysin. The asterisks highlight the locations of the peptides used to elicit 
the 4624, 4888, and 3645/3646 antibodies. The peptide sequence for 3645/3646 is common to all variants thus this antibody should rec-
ognize all expressed variants. Antibodies 4624 and 4888 recognize INV.v1 and INV.v2, respectively. (B) Schematic representing transcripts 
of the two alternatively-spliced N-terminal variants of human invadolysin and the location of primers Hv2f and Hv2r with the predicted size 
of RT-PCR amplicons. (C) RT-PCR using Hv2f and Hv2r demonstrates that transcripts for INV.v1 and INV.v2 are present and do not appear to 
change appreciably throughout SGBS adipogenesis (though INV.v1 is more prevalent). (D) Schematic representing alternatively-spliced exon 
12 INV.+37 and INV.Δ37 variants of human invadolysin and the location of primers H12f and H12r flanking exon 12 with the predicted size of 
RT-PCR amplicons. (E) RT-PCR using primers H12f and H12r demonstrates that transcripts for the INV.+37 and INV.Δ37 variants are present 
and do not appear to change appreciably throughout SGBS adipogenesis (though the INV.+37 variant is more prevalent). The most common 
RNA species based on this analysis is HsINV.v1+37.
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Figure 10: Invadolysin increased during adipogenesis of SGBS cells.
(A) Images of SGBS cells stained for LDs with LipidTox (red) and DNA with DAPI (blue) at time points during adipogenesis. Scale bar = 50 μm. 
(B) Protein extracts at different time points were probed with the 3646 invadolysin antibody. Immunoblotting showed that a 66 kDa form 
of invadolysin increased from day 8 of adipogenesis, while the level of a 52 kDa form of invadolysin did not change (*the 52 kDa band is 
detected by the secondary antibody alone and therefore unrelated to invadolysin). The 66 kDa form of invadolysin is close to the predicted 
full-length form (Table 1). (C) Immunoblotting of protein extracts from different time points with 4624 detected a 39 kDa band during 
adipogenesis. The 39 kDa band may represent a pro-region cleaved from INV.v1. (D) Immunoblotting of extracts with 4888 demonstrated 
an increase in 39 and 66 kDa forms of INV.v2 (* the 52 kDa band is detected by the secondary antibody alone and therefore unrelated to 
invadolysin).
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Table 1: Predicted molecular weight of invadolysin variants.
Alternative splice 
variant
  Number of amino acids 
(unprocessed)
  Predicted mol. 
weight (kDa)
HsINV.v1   692  78.12
HsINV.v1Δ37   655  73.58
HsINV.v2   640  72.79
HsINV.v2Δ37   603  68.25
The predicted molecular weights (Sequence manipulation suite) of 
the different alternatively-spliced variants of human invadolysin are 
based on the amino acid sequence. Invadolysin variant INV.v1 con-
tains a predicted signal sequence, and 37 amino acid exon 12. It has 
the highest predicted (unprocessed) molecular weight of 78.12 kDa. 
The variant INV.v2Δ37 lacks a signal sequence and exon 12. This 
variant has the lowest predicted (unprocessed) molecular weight 
amongst the four variants, at 68.25 kDa. As any potential process-
ing of invadolysin has yet to be defined, it has not been included in 
these measurements.
Table 2: A qualitative summary for the change of invadolysin variant levels during SGBS adipogenesis.
Mol. weight of detected bands (kDa)  Day 0  Day 3  Day 6  Day 9   Day 12   Day 14
Antibody 3646: raised against a sequence common to all forms of invadolysin
 66   N/C   N/C   N/C   +   ++   +++
 a52   N/C   N/C   N/C   N/C   N/C   N/C
Antibody 4624: raised against a peptide sequence found only in INV.v1
 39   N/C   N/C   N/C   N/C   N/C   −
Antibody 4888: raised against a peptide sequence found only in INV.v2
 66   N/C   N/C   N/C   +   ++   +++
 a52   N/C   N/C   N/C   N/C   N/C   N/C
 39   N/C   N/C   N/C   +   +   +++
The table summarizes the change in invadolysin variant levels as observed using different antibodies. ‘N/C’ indicates no observable change 
in variant level whereas ‘+’ and ‘−’ represent an increase and decrease in variant level, respectively. The 3646 antibody which is designed 
against a region common to all variants and the 4888 antibody which is designed against a region specific to INV.v2 show a similar pattern 
in the level of the 66 kDa form of invadolysin. aWe have determined that the 52 kDa form is detected by the secondary antibody alone and 
therefore unrelated to invadolysin.
was unchanged (Figure 11B [3646]). Blocking TOR kinase 
resulted in an intermediate impact on the 66  kDa band, 
but not on the 52  kDa band (Figure 11B [3646]). Similar 
results were observed when probing for INV.v2 (Figure 11B 
[4888]): the 52 kDa and 66 kDa forms of invadolysin were 
decreased upon inhibition of PI3K, but less so by inhibi-
tion of TOR kinase.
Akt lies downstream of PI3K in the insulin-signaling 
cascade and represents a critical node in the pathway 
(Taniguchi et al., 2006). A decrease in pAkt was observed 
upon PI3K inhibition, demonstrating that the insulin 
pathway was indeed impaired. TOR kinase inhibition 
did not affect the pAkt level, as TOR lies downstream 
of Akt. These results suggest that the change in INV.v2 
may be effected downstream of PI3K, but upstream of 
TOR. Our results further strengthen the hypothesis that 
invadolysin may play an important role in adipogenesis.
Discussion
The invadolysin gene encodes a conserved metalloprotease 
of the M8 family. The loss of invadolysin in Drosophila 
results in late larval lethality and a range of pleiotropic 
phenotypes including defects in mitotic progression, cell 
migration and mitochondrial function as well as accu-
mulation of nuclear envelope proteins and mono-ubiqui-
tinated Histone H2B (McHugh et al., 2004; Di Cara et al., 
2013; Rao et al., 2015). Invadolysin is localized to LDs, and 
invadolysin mutant larvae fail to accumulate triglycerides 
(Cobbe et al., 2009).
Herein we have demonstrated that insulin signaling is 
impaired in D. invadolysin mutants, with consequences on 
the INV.v2 66 kDa protein suggests a potential role for this 
form during SGBS adipogenesis in vitro.
Inhibition of PI3K blocked the increase in 
invadolysin during SGBS adipogenesis
To further examine the correlation between invadoly-
sin increase and adipogenesis, we inhibited adipogen-
esis by blocking PI3K and TOR kinase, two downstream 
mediators of insulin signaling (El-Chaâr et  al., 2004; 
Aubin et al., 2005). We used wortmannin and LY29004 
to inhibit PI3K, and rapamycin to inhibit TOR kinase 
(Figure 11A) (Vlahos et  al., 1994; Norman et  al., 1996; 
Oshiro et al., 2004). Blocking PI3K prevented the increase 
of the 66 kDa form of invadolysin, while the 52 kDa form 
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Figure 11: Effect of PI3K and TOR inhibitors during SGBS adipogenesis.
(A) A simplified schematic of the insulin/TOR pathway with key components such as insulin, insulin receptor, IRS (Insulin Receptor Sub-
strate), PI3K, PDK, PKC, Akt, TOR kinase depicted. Wortmannin and LY294002 inhibit PI3K, while rapamycin is an inhibitor of TOR kinase. 
Inhibitors were added to SGBS cells on day 7 following induction of adipogenesis. (B) Immunoblotting of SGBS extracts using 3646 and 
4888 invadolysin antibodies. The increase in the 66 kDa form of invadolysin (detected by both 3646 and 4888 antibodies) was diminished 
when adipogenesis was inhibited by PI3K inhibition, but less so by the inhibition of TOR kinase. *The 52 kDa form that remained constant 
during adipogenesis is detected by the secondary antibody alone and therefore unrelated to invadolysin. These results suggest that the 
level of INV.v2 might be regulated downstream of PI3K and upstream of TOR. The levels of pAkt decreased on days 12 and 14 upon addition 
of Wortmannin and LY294002, demonstrating inhibition of PI3K. The level of pAkt remained constant upon addition of Rapamycin (TOR 
inhibitor) as TOR is downstream of PI3K and Akt in the insulin signaling pathway.
the level of Lsd2, a protein that normally facilitates lipid 
storage. The localization of invadolysin to LDs during de 
novo formation of LDs is Protein Kinase C dependent. The 
N-terminus of invadolysin can be phosphorylated by PKC 
in vitro, suggesting that invadolysin may be phosphoryl-
ated in vivo. PKC is therefore a candidate for regulating 
the localization of invadolysin. Interestingly, invadolysin 
appears to localize differentially during distinct stages of 
3T3-L1 adipogenesis, localizing to LDs during the early-mid 
stages of differentiation, but then appearing more homo-
geneously dispersed in later stage adipocytes. The level 
of invadolysin was significantly increased in both murine 
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3T3-L1 and human SGBS in vitro adipogenesis models. The 
increase in invadolysin was prevented when adipogenesis 
was blocked by PKC or PI3K inhibitors in 3T3-L1 cells, and 
PI3K inhibition in SGBS cells.
Invadolysin and insulin signaling
Examination of D. invadolysin mutants demonstrated that 
invadolysin plays a role in insulin signaling. The size of 
invadolysin mutant larvae is smaller than that of wild type 
larvae at the same stage. This is a common phenotype of 
Drosophila mutants in the insulin signaling pathway, which 
is known to play a crucial role in growth and metabolism 
(Garofalo, 2002; McHugh et  al., 2004). We have previ-
ously demonstrated that the triglyceride:protein ratio was 
significantly reduced in invadolysin mutants compared to 
wild type animals (Cobbe et al., 2009). We have here shown 
that the glycogen:protein ratio is also decreased while 
autophagy is increased in invadolysin mutants. Our results 
confirmed that the level of active (phosphorylated) forms 
of pAkt and the downstream S6K and 4E-BP effectors of 
the insulin/TOR pathway were all decreased in invadolysin 
mutant larvae. These observations suggest that invadolysin 
may positively regulate the insulin signaling pathway, as 
insulin signaling positively affects fatty acid and glycogen 
synthesis, and negatively affects autophagy via TOR (Halse 
et al., 2001; Jung et al., 2010; Wong and Sul, 2010).
Insulin signaling has been implicated in the control 
of lipid metabolism in flies and mice. Both S6K and 4E­BP 
mutant mice are lean and resistant to diet-induced obesity 
(Tsukiyama-Kohara et  al., 2001; Um et  al., 2004). 4E­BP 
mutant flies show increased sensitivity to nutrient depriva-
tion, leading to abnormal fat loss (Teleman et al., 2005). Akt 
promotes the transcription of genes involved in lipid bio-
synthesis and storage pathways (Eberlé et al., 2004; Veresh-
chagina and Wilson, 2006). Activation of Akt in Drosophila 
nurse cells results in the accumulation of Lsd2 (a homologue 
of perilipin) (Vereshchagina and Wilson, 2006). A decrease 
of pAkt and Lsd2 were observed in invadolysin mutant larvae. 
Recently, we have performed a microarray analysis to identify 
genes with altered expression in invadolysin mutant larvae. 
This analysis revealed an increase of 4E-BP and decrease of 
Lsd1 (another PAT family protein in Drosophila). These data 
will be detailed in a subsequent manuscript.
Lsd2 mutants exhibit impaired lipid storage, thus 
mutant larvae appear less opaque with a decreased triglyc-
eride content than wild type larvae (Teixeira et al., 2003). 
We also documented decreased triglyceride:protein in inv­
adolysin mutant larvae (Cobbe et al., 2009), which might 
be a consequence of decreased Lsd2. Drosophila wild type 
larvae accumulate significantly higher triglyceride on a 
high sucrose diet (Musselman et al., 2011). The ability to 
accumulate higher triglyceride levels on a high sugar diet 
was impaired in invadolysin mutant larvae. In light of these 
data, we hypothesize that invadolysin plays a homeostatic 
role, possibly by positively regulating insulin signaling.
The localization of invadolysin to nascent 
LDs was dependent on PKC activity
Invadolysin is the first metalloprotease reported to localize 
to LDs. Studies have shown that proteins can be anchored 
to LDs via a GPI anchor or via a N-terminal hydrophobic 
sequence (Müller et  al., 2008; Zehmer et  al., 2008). In 
this study, we showed that targeting of invadolysin to LDs 
was dependent on PKC activity. Treatment with a general 
PKC inhibitor decreased the formation of LDs in cells and 
caused invadolysin aggregates to form in the cytosol. 
When the PKC inhibitor was removed, invadolysin relo-
calized to LDs, suggesting that PKC activity plays a crucial 
role in regulating invadolysin’s localization in the cellular 
starvation/refeeding model.
The starvation/refeeding experiments suggested that 
invadolysin might be recruited to nascent LDs. Invadoly-
sin may bind to LDs via a hydrophobic GPI anchor, as 
there is a GPI-addition consensus sequence near the C-ter-
minus of invadolysin (Cobbe et al., 2009). However, in the 
presence of a PKC inhibitor, fewer LDs were formed in cells 
and invadolysin may be forced to remain cytosolic leading 
to the self-association of invadolysin hydrophobic tails to 
form intracellular aggregates.
The use of a PKC inhibitor suggested that invadolysin’s 
relocalization may also be regulated by PKC phosphoryla-
tion. Removal of the PKC inhibitor presumably resulted in 
the reactivation of PKC, during which the relocalization of 
invadolysin to LDs was observed, possibly because invad-
olysin could again be phosphorylated by PKC. An in vitro 
PKC assay revealed that targeting to LDs might be medi-
ated by phosphorylation of Thr 220 and/or Thr269 within 
the N-terminal half of invadolysin. Interestingly, it has also 
been shown that the recruitment of caveolin to LDs in high 
levels of oleic acid or cholesterol was dependent on Src 
and PKC activity (Le Lay et al., 2006; Blouin et al., 2008).
Invadolysin plays a role in in vitro 
adipogenesis
The levels and localization of LD binding proteins are 
dynamically regulated during adipocyte differentiation. 
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Expression of the LD binding proteins CGI-58 and ADRP 
increased during adipocyte differentiation. The mRNA of 
adipose triglyceride lipase (ATGL) increased at days 4 and 
6, but declined at day 8 during adipogenesis (Yamaguchi 
et  al., 2004; Zimmermann et  al., 2004). After a 10  min 
treatment of adipocytes with long chain fatty acids, small 
LDs emerged, surrounded by TIP47 and S3-12 (Wolins 
et al., 2006). Over the next hour of treatment, TIP47 and 
S3-12 still surrounded these small LDs, whereas ADRP was 
concentrated on intermediate LDs and perilipin on large 
LDs. The formation of LDs in the early stages appears to 
be important for their further growth (Brasaemle et  al., 
2004). In the later stages of adipogenesis, several LDs 
grew in size to more than 10 μm in diameter while the 
number of LDs drastically decreased. This suggests that 
the growth of LDs during adipocyte differentiation may be 
achieved by the successive fusion of LDs to one another.
Invadolysin displays a differential localization pattern 
during in vitro adipogenesis. In the early stages of differ-
entiation (days 2–4), numerous small LDs appeared with 
invadolysin ‘rings’. However, invadolysin appeared to be 
dispersed in the cytosol in day 8 adipocytes, and only 
bound small rather than large LDs in mature adipocytes 
(day 14). Invadolysin might be recruited to LDs during LD 
biogenesis in the early stages of adipogenesis (as observed 
in the starvation/refeeding model). An association of inv-
adolysin with LDs at early times might be important for 
the recruitment of other LD-associated proteins or for the 
maintenance of LDs. At later stages of adipogenesis (after 
day 6), a role for invadolysin might be substituted by other 
proteins.
Although invadolysin was not observed on large LDs 
in mature adipocytes, the invadolysin level increased 
significantly during both 3T3-L1 and SGBS adipogenesis. 
Inhibition of adipogenesis by addition of inhibitors to 
3T3-L1 and SGBS cells diminished the increase in invad-
olysin. The level of TIP47 did not change following inhibi-
tion of PKC and PI3K in 3T3-L1 cells, and TIP47 has been 
reported to be functionally unnecessary for adipogenesis 
(Yamaguchi et al., 2004). Our results shows a strong cor-
relation between an increase in invadolysin and adipo-
genesis. Whether invadolysin is essential for adipogenesis 
will be best addressed by genetic invadolysin knock-out 
models, either through the examination of conditional 
knock-outs in tissues of interest, or by the differentialtion 
of mouse embryonic fibroblasts (Tontonoz et  al., 1994; 
Yamakawa et al., 2008).
The process of adipocyte differentiation is modulated 
by the activity of numerous transcription factors, result-
ing in turn from activation of signaling pathways (Rosen 
and MacDougald, 2006). Many adipocyte-specific genes, 
including perilipin, are regulated by PPARγ, an essential 
transcription factor for adipogenesis (Rosen and Spiegel-
man, 2000). The presence of perilipin in 3T3-L1 cells 
would imply that the transcription factor PPARγ has been 
activated (Arimura et  al., 2004). We demonstrated that 
perilipin and invadolysin mRNA levels were dramatically 
increased at day 2 of adipogenesis (and even further at day 
4). This result suggested that the increase of invadolysin 
might be brought about by PPARγ or a downstream tran-
scription factor such as C/EBPα. In the presence of PKC 
and PI3K inhibitors, the level of PPARγ was decreased 
(Zhou et  al., 2006; Yu et  al., 2008). Inhibition of PPARγ 
or studies on PPARγ null animals may help to elucidate 
any links between PPARγ and invadolysin in adipogenesis 
(Barak et al., 1999; Rosen et al., 1999).
Overall, our work provides new insights into the local-
ization and role of invadolysin. Levels of p-Akt, p-S6K, 
p-4E-BP, and Lsd2 were decreased in invadolysin mutant 
larvae. The localization of invadolysin to newly synthe-
sized LDs was dependent on PKC activity. An increase 
of invadolysin was observed during adipogenesis and 
blocked in the presence of PKC or PI3K inhibitors. These 
results suggest that invadolysin might normally play a 
positive role in the insulin signaling pathway and subse-
quently regulate lipid homeostasis. All of these data imply 
that invadolysin is a strong candidate for positive regula-
tion of adipocyte differentiation via insulin signaling.
Materials and methods
Antibodies and reagents
Antibodies used in this work were 3645/6 = INV P1-Ab (Cobbe et al., 
2009), INV C-Ab1 (Cobbe et  al., 2009), 4624 (INV.v1 downstream 
of signal sequence: SLGSSPPCRHHVPS), 4888 (INV.v2 N-terminal 
region: SGLLGLRPGPEPVAL), perilipin (Sigma-Aldrich), TIP-47 (Pro-
gen), Akt, phospho-Akt 505, phospho-p70 S6 kinase Thr 398, and 
phospho-4E-BP Thr37/46 (all Cell Signaling, Genosphere, Paris, 
France). The invadolysin peptide antibodies were generated by 
Genosphere. Lsd2 antibodies were generously provided by Dr. Ron-
ald Kühnlein (Max Planck Institute, Munich) and Dr. Luis Teixeira 
(University of Cambridge). PKC inhibitors Ro31-8220, Cycloheximide, 
3-isobutyl-l-methylxantin (IBMX), dexamethasone (DEX) and insulin 
were purchased from Sigma-Aldrich. PI-3 kinase (PI3K) was obtained 
from Cell Signaling.
Cell culture
Cells were cultured in a humidified incubator at 37°C with 5% CO2. 
For HeLa (human cervical carcinoma) and A375 (human melanoma) 
cells, DMEM (Dulbecco’s Modified Essential Medium, GIBCO) with 
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10% FBS was used. For 3T3-L1 cells (mouse embryonic fibroblasts), 
DMEM with 10% newborn calf serum (NCS) was used. For starva-
tion and refeeding experiments, cells were starved in DMEM without 
serum for 24 h, and cells were refed with DMEM containing 10% FBS 
and 10 μm oleic acid (Sigma-Aldrich). In some experiments, inhibi-
tors were added 1 h before supplementing the medium with 10% FBS 
and 10 μm oleic acid.
Adipocyte differentiation
3T3-L1 differentiation: Mouse embryonic 3T3-L1 cells were cultured 
in DMEM + 10% NCS until confluent. Two days after confluence, cells 
were stimulated with DMEM + 10% FBS containing 100 μm IBMX 
(Sigma, I7018), 0.25 μm DEX (Sigma, D4902) and 1 μg/ml insulin 
(Sigma, I5500). A change of cellular morphology was observed over 
the next 48 h. After stimulation, the culture medium was replaced 
with fresh medium containing 1 μg/ml insulin every 48 h for 2 times. 
Afterwards, the culture medium was replaced with DMEM + 10% FBS 
medium. At day 8, cells were fully differentiated (Student et al., 1980).
SGBS differentiation: SGBS cells are a human preadipocyte cell 
line obtained from subcutaneous white adipose depot of a patient 
suffering form SGBS disease (Wabitsch et al., 2001). These cells can 
be stimulated to be differentiated into adipocytes. For adipogenesis 
of SGBS cells, previously established protocol by Posovsky et al. was 
used (Fischer- Posovszky et  al., 2008). SGBS cells were cultured in 
DMEM/F12 (life technologies) medium supplemented with 10% fetal 
bovine serum and containing 33 μm biotin and 17 μm pantothenic 
acid. For initiating adipogenesis the cells were allowed to reach 90–
95% confluency. On day 0, adipogenesis is initiated in a DMEM/F12 
medium with 33 μm biotin and 17 μm pantothenic acid in absence of 
serum containing a cocktail of drugs (0.1 μm cortisol, 20 nm insulin, 
250 nm dexamethasone, 500 μm IBMX and 2 μm rosiglitazone). On 
day 3, rosiglitazone was withdrawn from the differentiation medium 
and on day 7, IBMX and dexamethasone were removed. The cells 
were allowed to differentiate until day 14 under these conditions.
RT-PCR and qPCR
Total RNA from cultured cells or Drosophila larvae was extracted 
using the RNeasy® Mini Kit (Qiagen, 74104) according to manufac-
turer’s instructions and as previously described (Cobbe et al., 2009). 
RT-PCR reactions were performed using Superscript III reverse 
transcriptase (Invitrogen) in 20 μl reactions according to the manu-
facturer’s instructions. PCR reactions were performed with prim-
ers designed to span exon boundaries. qPCR was performed using 
the LightCycler® 480 System and the LighterCycler® 480 probes 
 Master kit (Roche). Primers and probes used in qPCR reactions were 
designed by Universal Probe Library Assay Design Center by entering 
the sequence ID from Ensembl.
In vitro kinase assay
The in vitro phosphorylation assay of invadolysin was performed 
at 30°C in a 20 μl reaction. The reaction contained 1 × kinase buffer 
(25 mm Tris-HCl pH7.5, 5 mm β-glycerophosphate, 2 mm DTT, 0.1 mm 
Na3VO4, 10 mm MgCl2), 200 μm cold ATP (Cell Signaling, 9804), 1 μg 
of purified protein kinase C (Calbiochem, 539494), 0.1–1 μg of sub-
strate, and 0.2 μl of γ-32P-ATP (Perkin Ekmer, 250UC, NEG 502Z). After 
a 30 min incubation, 10 μl of 3 × SDS-PAGE sample buffer [6% SDS, 
150 mm upper buffer Tris (pH6.8), 30% Glycerol, 0.03% Bromophenol 
blue, 6 mm EDTA] was added to the reaction mixture and the mix-
ture was boiled for 10 min. The samples were then resolved by 4–12% 
SDS-PAGE. After electrophoresis, the gel was transferred to Whatman 
blotting paper and dried for 2 h in a heated gel dryer. The dried gel 
was exposed to Lumi-Film Chemiuminescent detection film.
Preparation of protein extracts
From cultured cells: Medium was removed and the cells were rinsed 
with PBS. 200 μl of RIPA lysis buffer with protease inhibitors (Roche 
Protease Inhibitor Cocktail Tablets) were added into each well of a 
6-well plate (35  mm culture dish), the cells were scraped and the 
resulting cell lysate was then transferred to a 1.5 ml Eppendorf tube. 
The lysate was mixed with 100 μl of 3 × SDS-PAGE sample buffer 
confaining DTT and the mixture was sonicated 5 times (2 s sonica-
tion with 5 s rest intervals), and subsequently boiled for 10 min. To 
remove the debris, the tube was centrifuged at 10 000 g for 2  min 
at 4°C, and the supernatant was collected and stored at −20°C until 
required.
From larvae: 3-day-old adult flies of the appropriate genotype 
were transferred into a cage containing an apple juice agar plate 
with fresh yeast paste and allowed to lay eggs for 24 h. Adult flies 
were then removed and the plate with eggs was placed in a 25°C 
incubator. 72 h after hatching from eggs, approximately 8–10 larvae 
were transferred to a vial containing fresh fly food supplemented 
with yeast paste. 24 h later, larvae of the appropriate genotype were 
collected (5 wild type larvae and 15 mutant larvae), rinsed with PBS 
and transferred to 1.5  ml Eppendorf tubes with 100 μl EBR lysis 
buffer (Ephrussi-Beadle Ringer’s: 130 mm NaCl, 4.7 mm KCl, 1.9 
mm CaCl2, 10 mm HEPES, pH6.9) with protease and phosphatase 
inhibitors. The larvae were homogenized on ice with a hand pestle. 
Another 200 μl of ice cold EBR lysis buffer was added to the tubes 
and mixed gently by pipetting. The homogenate was mixed with 
150 μl of 3 × SDS-PAGE sample buffer and 10 μl of 1M DTT. The mix-
ture was then sonicated for 2 s with 5 s rest intervals for 5 times and 
subsequently boiled for 10 min. To remove the debris, the tube was 
centrifuged at 10 000 g for 2 min at 4°C, and the supernatant was 
collected and stored at −20°C.
From larval fat body: 96-h-old larvae of the appropriate geno-
type were collected and rinsed in a glass dish pre-filled with cold 
PBS and protease inhibitors. The larvae were dissected by the ‘pull 
and drag’ method with two pairs of forceps. This method exposes 
all internal organs to the PBS. The fat bodies were transferred to an 
Eppendorf tube containing 100 μl EBR lysis buffer (10 fat bodies from 
wild type and 40 fat bodies from invadolysin mutant were collected). 
The fat bodies were then homogenized on ice with a hand pestle. 
Another 200 μl of cold EBR lysis buffer was added to the tubes and 
mixed gently by pipetting. The homogenate was mixed with 150 μl 
of 3 × SDS-PAGE sample buffer and 10 μl of 1M DTT. The mixture was 
then sonicated for 2 s with 5 s rest intervals for 5 times and subse-
quently boiled for 10 min. To remove the debris, the tube was centri-
fuged at 10 000 g for 2 min at 4°C, and the supernatant was collected 
and stored at −20°C.
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SDS-PAGE and immunoblotting
Cell lysates were subjected to SDS-PAGE and immunoblotted as pre-
viously reported (Cobbe et al., 2009). Nitrocellulose membranes were 
probed with desired antibodies. Primary antibody detection was 
performed using an appropriate horseradish peroxidase-conjugated 
IgG, and the immune-signal was detected by ECL (GE Healthcare) 
with Lumi-Film Chemiluminescent detection film (Roche).
Immunofluorescence
The procedures used were previously described (Cobbe et al., 2009). 
Cultured cells were seeded overnight onto round cover slips. Cover 
slips were removed from the culture dish and fixed for 3  min with 
4% formaldehyde and cells permeabilised with PBS containing 
0.1% TX-100 for 3 min. After washing twice with PBST (PBS contain-
ing 0.05% TX-100), cells were blocked with PBS + 3% BSA at room 
temperature for 30 min. After washing twice in PBST, cells were 
incubated with primary antibody for 1 h at room temperature. After 
washing 3 times in PBST, cells were incubated with the secondary 
antibody at room temperature for 45 min. After washing 3 times in 
PBST, the cover slips were mounted on glass slides with a Mowiol 
solution. Cells were visualized with an Olympus AX-70 Provis epif-
luorescence microscope equipped with a Hamamatsu Orca II CCD 
camera and SmartCapture3 software.
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